Amidst the COVID-19 pandemic and global lockdown, the National Institute for Pharmaceutical Research and Development (NIPRD) has got international reaccreditation.
The reaccreditation means that testing and other outcomes, including for coronavirus, which emanates from the institute are internationally accepted.
The reaccreditation of NIPRD by the American Accreditation Board (ANAB) for the ANAB certificate ISO/IEC 17025:2017 in Quality Management System was carried out in March and April this year. Following the recent reaccreditation, NIPRD’s ISO certificate is valid till June 2022.
A statement yesterday by the institute said NIPRD achieved the reaccreditation amidst COVID-19 pandemic via remote assessment undertaken by a team headed by Professor Diallo Rassoulou who led the process from Canada.
This is the first time that this mode of assessment is being used in the region.
The Director-General of the agency, Dr Obi Adigwe, attributed the achievement to the recent improved information technology capabilities and competencies in the institute.
